A FDA-approved molecule identified through structure-based drug designing methodology has been found to be effective against kala-azar. In vitro studies show the molecule to be less toxic than the drug currently being used to treat kala-azar. Combining structure-based drug designing methodology with in vitro studies, scientists have been able to identify a FDA-approved molecule that shows enhanced … Continue reading Novel inhibitor to combat kala-azar identified